Several lines of evidence suggest that gastrin and the CCK-2 receptor (CCK2R) could contribute to pancreatic carcinogenesis by modulating processes such as proliferation, cell adhesion or migration. In the current study, we used a 'cancer gene array' and identified b1-integrin subunit as a new gastrin-regulated gene in human pancreatic cancer cells. We also demonstrated that Src family kinases and the phosphatidylinositol-3-kinase (PI-3-kinase) pathway play a crucial role in the expression of b1-integrin induced by gastrin. Our results also showed that gastrin modulates cell-substrate adhesion via b1-integrin. Indeed, using blocking anti-b1-integrin monoclonal antibodies, we completely reversed the increase in cellsubstrate adhesion induced by gastrin. In addition, we observed that in response to gastrin, b1-integrin is tyrosine phosphorylated by Src family kinases and associates with paxillin, a scaffold protein involved in focal adhesion and integrin signalling. This mechanism might be involved in gastrin-induced cell adhesion. Moreover, we showed in vivo that targeted CCK2R expression in the pancreas of Elas-CCK2 mice leads to the overexpression of b1-integrin. This process may contribute to pancreatic tumour development observed in these transgenic animals.
Introduction
CCK2 receptor (CCK2R) belongs to the superfamily of seven transmembrane domain receptors. This receptor was initially implicated in secretory effects of a digestive peptide hormone, gastrin. However, CCK2R is now recognized to mediate the mitogenic and antiapoptotic effects of gastrin on gastrointestinal cells (Aly et al., 2004) . Although the stomach is the main target of gastrin, the role of CCK2R in proliferation of different pancreatic tumour cell lines has also been described (Smith et al., 1995 (Smith et al., , 1996 (Smith et al., , 1999 Kaufmann et al., 1997) . In addition, several studies have reported the expression of gastrin and its receptor in human pancreatic cancer cells as well as in preneoplastic pancreatic lesions ('pancreatic Intraepithelial Neoplasia': PanIN) (Smith et al., 1998; de Weerth et al., 1999; Caplin et al., 2000; Prasad et al., 2005) .
In the transgenic mice Elas-CCK2, CCK2R expression has been targeted in pancreatic acinar cells, using transcriptional elements of the elastase-1 gene (Clerc et al., 2002) . We have reported in this model (i) an increased pancreatic growth, (ii) an acinar to ductal transdifferentiation, postulated to be a preneoplasic step in pancreatic carcinogenesis and (iii) development of tumours (Clerc et al., 2002) . Similar observations have been reported in two other transgenic models overexpressing TGF-alpha or a K-ras mutant in exocrine pancreas (Wagner et al., 1998; Grippo et al., 2003) .
Besides secretory and proliferative effects, gastrin also modulates cell adhesion and migration. We and others have previously demonstrated that prolonged activation of CCK2R by gastrin induces stress fibre formation, alters cell morphology, increases loss of cell-cell adhesion, and motility of epithelial cells in vitro (Taniguchi et al., 1996; Bierkamp et al., 2002; Noble et al., 2003; Ferrand et al., 2004) . In addition, we have recently shown loss of intercellular adhesion in acini of Elas-CCK2 mice before tumour formation (Bierkamp et al., 2004) .
Several signalling pathways activated by CCK2R have been implicated in the proliferative effects or cell migration induced by gastrin. They include mitogen activated protein-kinases (Todisco et al., 1997; Daulhac et al., 1999b) , the phosphatidylinositol 3-kinase and the JAK2/STAT3 pathway (Kowalski-Chauvel et al., 1996; Ferrand et al., 2004 Ferrand et al., , 2005 . In addition, Src family tyrosine kinases and p125FAK have also been shown to play a crucial role in these gastrin biological effects (Daulhac et al., 1999a, b) .
In gastric epithelial cells, numerous target genes of CCK2R have been already identified. They include genes involved in gastric acid secretion (Hocker, 2004) , early response genes, c-Fos (Stepan et al., 1999b) , c-Jun and c-Myc (Taniguchi et al., 1994; Wang et al., 1995) and other growth-related genes such as cyclin D1 (Zhukova et al., 2001) , Reg-1 (Fukui et al., 1998) or HB-EGF (Sinclair et al., 2004) . In addition, in the same cellular model, gastrin also regulates the expression of genes associated with cell migration and invasion, such as MMP9, a matrix metalloproteinase (Wroblewski et al., 2002) . In several cellular models such as gastric and colonic cancer cells, intestinal epithelial cells or fibroblasts stably transfected, gastrin also enhances cyclooxygenase-2 (COX-2) expression, known to play an important role in inflammation processes and carcinogenesis (Guo et al., 2002; Slice et al., 2003; Colucci et al., 2005) . In contrast, to our knowledge, no gastrin-regulated genes have been identified in pancreatic models expressing the CCK2R. Using a 'cancer genes' array, we identified in the present study b1-integrin as a new gastrin target gene in the human pancreatic cancer cell line, Panc-1. Integrins that mediate cell adhesion play an important role in cell migration, survival and differentiation. Here we show in vitro that b1-integrin is involved in the modulation of cell adhesion by CCK2R. Moreover, we demonstrate in vivo that the targeted CCK2R expression in the pancreas of Elas-CCK2 mice, which present preneoplastic lesions and develop pancreatic tumours, leads to b1-integrin expression.
Results
Expression of the cholecystokinin-2 receptor in the human pancreatic cancer cell line Panc-1 In initial experiments, RNA from the human pancreatic cancer cell line, Panc-1, was analysed by reverse transcription-PCR (RT-PCR) for the presence of CCK2R. As shown in Figure 1a , CCK2R was detected in the Panc-1 cell line (lane 2) as demonstrated by the presence of a 317-bp fragment. In the absence of cDNA (lane 1), no amplification of mRNA CCK2R was detected, confirming that the positive band was generated from the amplification of cDNA.
Gastrin increases b1-integrin expression in Panc-1 cells In order to identify new gastrin-regulated genes, a human cancer array of 96 genes was probed with samples from either control Panc-1 cells or cells treated with gastrin for 24 h.
Among the genes positively modulated by CCK2R in these experiments, we observed a significant increase in the expression of b1-integrin subunit (approximately threefold) (Figure 1b) . A quantitative real-time PCR approach was used to confirm and quantify b1-integrin gene expression. The increase in b1-integrin gene expression in response to gastrin was time dependent: significantly detectable after 3 h of gastrin treatment, maximal at 24 h and decreasing at 48 h (Figure 1c) . Therefore, we used the time of 24 h to perform dosereponse experiments. b1-integrin mRNA was significantly increased with 1 nM gastrin. The maximal effect was observed for 10 nM, then decreasing at 100 nM ( Figure 1d ). In addition, we also confirmed by Western blot analysis the increase in protein levels of b1-integrin in gastrin-stimulated cells (Figure 1c ).
Signalling pathways involved in b1-integrin expression stimulated by gastrin As mentioned in the introduction, gastrin exerts its trophic effects and modulates cell adhesion through a variety of intracellular pathways dependent on the cellular model. Here we first identified the signalling pathways specifically activated by the CCK2R in the Panc-1 cells.
Using antibodies specific for the activated, phosphorylated forms of extracellular signal-regulated protein kinases, ERKs, or AKT, a downstream effector of the PI-3-kinase we performed Western blot analysis on cell lysates from Panc-1 cells incubated in the presence or absence of gastrin for the time indicated. We detected an increase in the phosphorylation of AKT and ERKs in response to gastrin, indicating that the PI-3-kinase pathway and the ERK pathway were activated (Figure 2a and b) . In addition, gastrin stimulates Src-kinase activity in Panc-1 cells as shown in Figure 2c .
To determine the cellular mechanism by which gastrin could increase b1-integrin gene expression, we examined gastrin-regulated b1-integrin gene expression in Panc-1 Total RNA was isolated and b1-integrin mRNA expression was determined by real-time PCR as described in Materials and methods. (e) Expression of b1-integrin protein was examined by Western blot analysis following treatment of the cells with gastrin for 24 h. Blots were also probed with an antibody against glyceraldehydes-3-phosphate dehydrogenase (GAPDH) to ensure equal loading of proteins. Representative data from three experiments are shown.
Cholecystokinin-2 receptor modulates cell adhesion C Cayrol et al by quantitative real-time PCR in the presence of different specific inhibitors, LY294002, PP2, or PD 098059 that block respectively the PI-3-kinase pathway, Src family kinases and the ERK pathway. When cells were preincubated with PP2, gastrin response was decreased by 80% and totally blocked in cells pretreated with LY294002 (Figure 2d ), indicating that Src family kinases and the PI-3-kinase pathway mediate gastrinincreased b1-integrin gene expression in Panc-1 cells.
In contrast, inhibitor of the ERK pathway was without any effect (data not shown).
Effect of gastrin on Panc-1 cell adhesion Here, we have identified b1-integrin as a new gastrin target in Panc-1 cells. Integrins act as adhesion receptors linking the extracellular matrix to the cytoskeleton. For many cell types, integrin-mediated adhesion is required for cell growth and cell survival. In the second part of this study, we investigated whether gastrin had an effect on Panc-1 cell adhesion. In cell adhesion assays using fibronectin-or laminin-coated wells, we show that gastrin induces a significant increase in Panc-1 cell adhesion to both basement membrane constituents ( Figure 3a and b, bars in grey). As expected in bovine serum albumin (BSA) alone controls, we did not observe any effect of gastrin on cell adhesion (Figure 3c ).
To determine the role of b1-integrin in gastrinenhanced Panc-1 cell adhesion, we used blocking antib1-integrin monoclonal antibodies. When added 30 min before gastrin stimulation the antibodies significantly decrease gastrin-stimulated Panc-1 cell adhesion ( Figure 3 ). This confirms that b1-integrin plays an important role in Panc-1 cell adhesion stimulated by gastrin.
Gastrin induces tyrosine phosphorylation of b1-integrin in Panc-1 cells It is known that tyrosine phosphorylation of certain integrins, such as b3-integrin, is required for cell adhesion modulation. Consistent with these finding, we tested whether gastrin could induce tyrosine phosphorylation of b1-integrin in Panc-1 cells. Using antibodies specific for the phosphorylated forms of b1-integrin, we performed Western blot analysis on cell lysates from Panc-1 cells incubated in the presence or absence of gastrin for the time indicated. As shown in Figure 4a , gastrin treatment induced a rapid tyrosine phosphorylation of b1-integrin. In addition, an increase in the amount of paxillin co-precipitated with b1-integrin was detected in response to gastrin ( Figure 4b ). Both b1-integrin phosphorylation and the association between paxillin and b1-integrin were inhibited in the presence of the specific Src-kinase inhibitor PP2 (Figure 4a and b).
Gastrin influences focal contact formation in Panc-1 cells As markers of focal contact, we next investigated the cellular localization of focal adhesion kinase (FAK) and paxillin, by fluorescence microscopy. In gastrin-stimulated cells, the number of focal contacts stained by antibodies against FAK or paxillin was greatly increased Immunohistochemical staining of b1-integrin in the pancreas of Elas-CCK2 mice We recently described the Elas-CCK2 mice expressing the human CCK2R in acini. These mice exhibit an increased pancreatic growth, an acinar to ductal transdifferentiation, postulated to be a preneoplasic step in pancreatic carcinogenesis, and develop tumours. Thus to analyse in vivo the relevance of b1-integrin expression in response to CCK2R activation, we studied, by immunohistochemistry methods, b1-integrin overexpression on pancreatic tissue sections from Elas-CCK2 mice or control mice. As shown in Figure 6a , tissues derived from Elas-CCK2 mice showed an upregulation of b1-integrin (right panel) as compared to control mice (left panel).
To confirm the upregulation of b1-integrin, Westernblotting analyses were performed on lysates of acinar cells isolated from pancreas of control and Elas-CCK2 mice. b1-integrin in Elas-CCK2 mice was significantly elevated as compared to controls (Figure 6b) . Thus, targeting the CCK2R in mouse pancreatic acini induces b1-integrin expression.
Blockage of CCK2Rs in the Elas-CCK2 mice by subcutaneous injections of a specific antagonist, CR2945 (Fontana et al., 1999) , for 8 weeks, inhibited gastrininduced b1-integrin expression (Figure 6c ). Under the same conditions, CR 2945, by interfering with pancreatic CCK2R, reverses hypertrophy resulting from functional expression of the transgene in acinar cells (Figure 6d ) that was previously described in this model (Clerc et al., 2002) .
Discussion
Integrins are cell-surface receptors that comprise an expanding family of transmembrane heterodimers of a and b subunits. Upon binding to components of the extracellular matrix, integrins associate with elements of the cytoskeleton modulating its organization. They also interact with intracellular proteins to initiate signal transduction cascades (Giancotti and Tarone, 2003) . They are not only crucial for cell migration but also contribute to cell survival and proliferation. Several studies have demonstrated that integrins play a key role in malignant behaviour of neoplastic cells. They activate in particular signalling pathways necessary for tumour invasion and metastasis (see for reviews, Clark and Brugge, 1995; van der Flier and Sonnenberg, 2001; Guo and Giancotti, 2004) . They are also implicated in angiogenesis (Eliceiri and Cheresh, 2000) . Altered expression of integrins, in the form of down-or upregulated expression, has been detected in the majority of malignant tumours and appears to be one of the abnormalities involved in tumour progression. For example, it has been described that a2, a3, a5, a6, aV, b1-, b4-and b5-integrin subunits are overexpressed in certain pancreatic carcinomas (Shimoyama et al., 1995; Lohr et al., 1996; Halatsch et al., 1997) .
Numerous studies show that integrins and receptor tyrosine kinases (RTK) share many common signalling pathways (Giancotti and Tarone, 2003; Ross, 2004) . In Figure 5 Effect of gastrin on focal contact formation in Panc-1 cells. Cells were grown for 24 h on 12-well plates containing cover slides and then stimulated or not stimulated (control) with gastrin for 24 h. Cells were then fixed and stained with the indicated antibodies (anti-FAK or anti-paxillin) using standard immunofluorescence techniques. Slides were analysed on a Nikon E400 microscope with a Sony DXC 950 camera and Visiolab 2000 software. Images were further assembled using Adobe Photoshop software. For semiquantitative comparisons, identical volumes of antibody mix were used for all samples, and identical exposure times taken. Representative micrographs from three independent experiments are shown (original magnification Â 40).
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Cholecystokinin-2 receptor modulates cell adhesion C Cayrol et al addition, crosstalks and interactions between these two receptor families have been reported previously. Moreover, several growth factors such as epidermal growth factor (EGF), hepatocyte growth factor, platelet-derived growth factor and glial cell-derived neutrophic factor have been shown to modulate the expression of specific integrins, including in pancreatic cancer cells, influencing cell adhesion and migration (Chiu et al., 2002; Funahashi et al., 2003; Chao et al., 2005) . Crosstalks between integrins and certain G-protein-coupled receptors (GPCR) are also described in the literature. However, little information is available concerning the mechanisms involved. In addition, the role of GPCR in modulating integrin expression is not well defined. Gastrin, which is overexpressed in gastrointestinal and pancreatic cancers, is a growth factor that binds to GPCRs, CCK2R, and contributes to pancreatic carcinogenesis by modulating processes such as proliferation and cell-cell adhesion.
In the present study, we show that gastrin increases the expression of b1-integrin at the mRNA and protein level in a human pancreatic tumour cell line. We also investigated the signal transduction pathways by which gastrin modulates the expression of b1-integrin subunit. Our results demonstrate that Src family kinases and the PI-3-kinase pathway play a crucial role in b1-integrin expression, as gastrin-enhanced b1-integrin mRNA levels were decreased by specific inhibitors of these kinases. In contrast, PD98059, a specific ERK pathway inhibitor, displayed no inhibitory effect. To our knowledge, nothing is known about gene regulation by gastrin in pancreatic tumour models expressing CCK2R. However, in colon cancer cells, gastrin was shown to increase, through a PI-3-kinase-dependent mechanism, Immunohistochemistry analyses on paraffin-embedded pancreatic tissues (a and c) or Western blots on lysates from isolated acinar cells (b) were performed using antibodies specific for b1-integrin. In (b), blots were also probed with an antibody against GAPDH to ensure equal loading of proteins and the results of Western blots were quantified and presented as means7s.e.m. In (c) and (d), Elas-CCK2 mice received two daily subcutaneous injections of vehicle or CR2945 (30 mg/kg), a specific CCK2R antagonist, for 8 weeks. In (d), morphometric analysis to measure acinar cell area was performed as previously described (Clerc et al., 2002) . A 28% hypertrophy was observed in Elas-CCK2 mice as compared to control mice (Clerc et al., 2002) . Representative data from three experiments (three different animals in each group) are shown.
Cholecystokinin-2 receptor modulates cell adhesion C Cayrol et al COX-2 gene expression, a factor overexpressed in colon cancer and which plays an important role in tumour progression (Colucci et al., 2005) . In contrast, in gastric cells, regulation of several genes by CCK2R, including genes implicated in gastric acid secretion (Hocker, 2004) , and early response genes (Stepan et al., 1999a, b) , involves the activation of the ERK pathway.
As our results demonstrated increased expression of b1-integrin in response to CCK2R stimulation, we also examined the effects of gastrin on pancreatic tumour cell adhesion to extracellular matrix components. We found that gastrin increases PANC-1 cell adhesion to fibronectin and with a lower effect to laminin. In addition, we show that this increase is mediated by b1-integrin, as blocking anti-b1-integrin monoclonal antibodies completely reversed the increase in cell-substrate adhesion induced by gastrin. The rapid increase in cell adhesion, observed 2 h after gastrin treatment, might correspond to early activation of b1-integrin signalling, whereas the increase in b1-integrin expression maximal at 24 h in response to gastrin might contribute to maintain a high level of b1-integrin that participates in cell adhesion.
Activated integrins undergo conformational changes that allow their cytoplasmic domains to interact with numerous intracellular proteins. These interactions can be regulated in part by phosphorylations on tyrosine as well as on serine and threonine residues (Calderwood et al., 2003; Calderwood, 2004) . For example, tyrosine phosphorylation of the conserved NPxY motif in the b3-integrin cytoplasmic tail has been shown to provide a binding site for Pyk2, a tyrosine kinase known to play a critical role in adhesion and migration of many cell types (Jenkins et al., 1998; Butler and Blystone, 2005) . This interaction is required in avb3-integrin-mediated adhesion (Gao et al., 2005) . Here we show that gastrin induces a rapid tyrosine phosphorylation of b1-integrin and the subsequent recruitment of paxillin, a scaffold protein that localizes to focal contacts, and plays a central role in focal adhesion and integrin signalling. FAK is one of the numerous proteins that bind paxillin (Turner, 2000) . This tyrosine kinase is also activated by RTK as well as GPCR including CCK2R (Daulhac et al., 1999a) . Here we observed that the number of focal contacts stained by antibodies against FAK or paxillin was greatly increased by gastrin. These observations indicate that gastrin-stimulated focal contact formation coincides with the increase in cell adhesion in response to gastrin that was observed and with b1-integrin overexpression.
Several publications suggest that Src family kinases regulate integrins signalling and contribute to integrinsdependent cell adhesion. In addition, Src proteins have been colocalized with integrin in focal complexes, and direct interaction between Src and the cytoplasmic tail of the b subunit of several integrins has been previously described (Felsenfeld et al., 1999; Playford and Schaller, 2004) . In this work, we show that gastrin activates Src in the panc-1 cells and that the tyrosine phosphorylation of b1-integrin in response to gastrin is dependent on Src family kinases. Our data suggest that Src might be responsible for b1-integrin phosphorylation and once phosphorylated, b1-integrin might recruit paxillin.
Another important finding of this study is that the expression of a GPCR, namely the CCK2R, targeted in mouse pancreatic acinar tissue, leads to overexpression of b1-integrin. These transgenic mice display an increased growth of the pancreas and develop preneoplastic lesions and then pancreatic tumours presenting a ductal phenotype similar to that observed in human pancreatic cancers.
Most pancreatic carcinomas are highly invasive. This process is a multistep process that includes not only the cell detachment from the primary tumour and migration through adjacent tissues but also the attachment of cells and their growth to metastasis sites. The integrins have been involved in all these processes. By modulating the adhesive properties of pancreatic tumour cells and in particular by increasing b1 expression and by activating b1-integrin signalling, gastrin might contribute to increase the aggressive behaviour of human pancreatic tumour cells.
Materials and methods
Cell culture
The human pancreatic cancer cell line, Panc-1, was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS) at 371C in a humidified atmosphere containing 5% CO 2. In all experiments, cells were serum-starved for 18 h before gastrin stimulation. Human gastrin 2-17ds (Bachem, Switzerland) was used in all the experiments.
RNA extraction and reverse transcription
Total RNA was isolated from 1 Â 10 7 Panc-1 cells either treated or not treated with gastrin for 24 h by using the RNeasy RNA Isolation Kit (Qiagen, Valencia, CA, USA). After pretreating RNA with 10 U DNase (Invitrogen, Carlsbad, CA, USA), cDNA was produced from 2 mg of total RNA, using the Superscript First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA, USA). PCR of the CCK2R was performed using the following primers: forward-TTGTTCTTCATCCCGGGTGT, reverse-CGCTTCTTAGC CAGCAGC.
'Cancer super array'
A specific 'cancer array' (96 genes) from SuperArray (Bioscience Corporation, Beverly, MA, USA) was used in this study. Total RNA was isolated from 1 Â 10 7 Panc-1 cells as described above. Reverse transcription of cellular RNA was carried out with the RT-Labeling Kit (SuperArray, Bioscience Corporation, Beverly, MA, USA) according to the manufacturer's instructions. The biotinylated probes from gastrinstimulated cells and unstimulated cells were hybridized overnight to separate membranes at 601C, washed with SSC/SDS solutions, incubated with the avidin-alkaline phosphatase conjugate and exposed to a chemiluminescent substrate. Analysis of the images and quantitation of the spots in both membranes were performed by the ScanAlyze 2.5 software, and normalization of the values and comparison of the intensities were achieved by the GE ArrayAnalyzer 1.3 (SuperArray, Bioscience Corporation, Beverly, MA, USA) software.
Real-time PCR b1-integrin mRNA expression in Panc-1 cells was determined by real-time PCR, using fluorescent SYBR green dye to allow semiquantitative analysis of gene expression levels. The resultant cDNA was diluted at 1:10 with sterile water for the subsequent real-time PCR. Real-time PCR was carried out in a 25 ml reaction volume containing 2 ml of diluted cDNA template, a final concentration of 1 Â SYBR Green Master Mix (Applied Biosystems, Framingham, MA, USA) and 300 nM forward and reverse primers (18S: forward-CGCAGC TAGGAATAATGGAATAGG, reverse-CATGGCCTCAGTTC CGAAA; b1-integrin: forward-TTTCGATGCCATCATGCAA, reverse-ACCAGCAGCCGTGTAACATTC). Reactions were carried out in ABI Prism 96-well optical reaction plates with 96-well optical covers (Applied Biosystems, Framingham, MA, USA). Amplification was conducted using ABI Sequence Detection System 5700 (SDS 5700), determined automatically by the SDS 5700 instrument and reported as a cycling threshold (C T ). Relative fold changes were determined using the 2 ÀDDCT method, in which the 18S gene was used for normalization. To calculate 2 ÀDDCT , first the triplicate C T values for the target gene (i.e., b1-integrin) and 18S were averaged. To determine the DC T values, the average 18S C T was subtracted from the average C T of the target gene for each sample. Then to determine DDCT, the DC T for the gastrinstimulated Panc-1 cells was subtracted from the DC T of the control cells. If DDC T was negative, then the gene was induced and the 2 ÀDDCT formula was used. Conversely, if DDC T was positive, then we reported the gene as repressed, and the fold repression was calculated using 2 DDCT .
Western blot analysis on isolated acinar cells or Panc-1 cells Western blot analyses were performed on (i) dispersed acini from mice pancreas prepared as previously described (Ferrand et al., 2005) or on (ii) lysates or immunoprecipitates from Panc-1 cells stimulated or not stimulated with gastrin. Fractions, containing identical levels of proteins, were separated by SDS-PAGE and analysed by Western blot with the indicated antibodies as described previously (KowalskiChauvel et al., 1996) . The immunoreactivity was visualized with an enhanced chemiluminescence system. Primary antibodies used were anti-b1-integrin from Chemicon International Inc. (Temecula, CA, USA) and anti-phospho-b1-integrin (Tyr783) from Biolegend Inc. (San Diego, CA, USA)
Src kinase assay After gastrin stimulation, cells were lysed and Src immunoprecipitated with specific p60-Src antibodies (Oncogene Science, Bayer Corporation, Cambridge, MA, USA). Kinase assays were performed and analysed as previously described (Daulhac et al., 1999b) . Proteins were separated by SDS-PAGE and the gel was autoradiographied.
Immunofluorescence Panc-1 cells were grown on 12-well plates containing cover slides coated with fibronectin. Cells were fixed in 2% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked in 1% FCS-PBS and incubated with primary antibodies (anti-FAK, Santa Cruz Biotechnology, CA, USA; anti-paxillin, BD Transduction Laboratories, CA, USA) according to standard immunofluorescence methods. Secondary antibodies coupled to fluorescein isothiocyanate were purchased from Jackson Immunoresearch Laboratories (West Grove, PA, USA). Slides were mounted in fluorescent mounting medium (DAKO, Glostrup, Denmark) and analysed on a Nikon E400 microscope with a Sony DXC 950 camera and Visiolab 2000 software. Images were assembled using Adobe Photoshop software. For semiquantitative comparisons, identical volumes of antibody mix were used for all samples, and identical exposure times taken.
Cell adhesion assay
Cell adhesion assays were carried out in 96-well plates. The wells were coated, or not, overnight with fibronectin or laminin diluted at 5 mg/ml in PBS, then washed twice with 100 ml PBS and blocked with 1% BSA-PBS for 30 min at room temperature before addition of the cell suspension. The cells were incubated for 2 h at 371C with or without gastrin. Adherent cells were fixed with 50 ml of 96% ethanol for 10 min, stained with 50 ml of 0.1% crystal violet, rinsed extensively with water and dried at room temperature. Stained cells were solubilized with 50 ml of 0.2% Triton X-100 and quantitated by measuring the absorbance at 570 nm. For adhesion inhibition experiments, cells were pretreated for 30 min at 371C with or without 5 mg/ml function-blocking antibodies directed against b1-integrin and either treated or not treated with gastrin for 2 h.
Animals
Homozygous Elas-CCK2 mice used in this study have been previously described (Clerc et al., 2002) . At least three 6-month-old homozygous Elas-CCK2 mice in a B6SJLF1 background and three corresponding control littermate mice were used. Mice were reared in the routine animal facility of IFR31 and maintained on a 12:12 h light-dark cycle. All the experiments were performed during daytime. All the procedures were approved by the IFR31 animal facility care committee. When indicated, Elas-CCK2 mice received two daily subcutaneous injections of vehicle or CR2945 at the dose of 30 mg/kg for 8 weeks before being killed. CR2945 was supplied by Rotta Research Laboratories (Monza, Italy).
Histology and immunohistochemistry
Mice were killed by decapitation, and pancreas excised, fixed in Bouin's solution and embedded in paraffin, using standard techniques. Immunohistochemistry was performed, as previously described (Ferrand et al., 2005) using anti-b1-integrin antibodies (Chemicon, Temecula, CA, USA). Sections were incubated with the appropriate secondary and tertiary peroxidase-labelled antisera (DAKO, Glostrup, Denmark) at room temperature, exposed to a solution of diaminobenzidine. All dilutions and washes were performed in PBS, pH 7.4, containing 0.1% BSA. Morphometric analysis to measure acinar cell area was performed as previously described (Clerc et al., 2002) .
Statistical analysis
Means7s.e.m. and Student's t-tests were performed using 'GraphPad Prism' (***Po0.001; **0.001oPo0.01; *0.01o Po0.05; ns P>0.05).
